Sanguibiotech GmbH
Records under this name other than patents Sanguibiotech GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to Sanguibiotech GmbH
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,005,414 | Synthetic oxygen transport made from cross-linked modified human or porcine haemoglobin with improved properties, method for a preparation thereof from purified material and use thereof Term ended Ended no later than Jun 12, 2021 · From the USPTO record | Term ended | Ended no later than Jun 12, 2021 | From the USPTO record |
| US 6,956,025 | Mammalian haemoglobin compatible with blood plasma, cross-linked and conjugated with polyalkylene oxides as artificial medical oxygen carriers, production and use thereof Lapsed on the fee record Ended Oct 18, 2017 · From the USPTO record | Lapsed on the fee record | Ended Oct 18, 2017 | From the USPTO record |
| US 7,598,220 | Use of hyperpolymeric hemoglobin for the treatment of pulmonary edema Lapsed on the fee record Ended Oct 6, 2017 · From the USPTO record | Lapsed on the fee record | Ended Oct 6, 2017 | From the USPTO record |
| US 5,985,332 | Hemoglobins provided with ligands protecting the oxygen binding sites for use as artificial oxygen carriers for direct application in medicine and biology, and method for the preparation thereof Term ended Term ended no later than Nov 16, 2019 · Low confidence | Term ended | Term ended no later than Nov 16, 2019 | Low confidence |
| US 5,994,509 | Method for obtaining uniform fractions of hyperpolymeric hemoglobins Term ended Term ended no later than Nov 30, 2019 · Low confidence | Term ended | Term ended no later than Nov 30, 2019 | Low confidence |